Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dronabinol for Marijuana Withdrawal and Rewarding Effects
NCT00893074Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- Apr 2009
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dronabinol in cannabis use disorder (CUD), sponsored by Johns Hopkins University. Started Apr 2009; status: completed.
02
Drugs
dronabinol
03
Conditions
cannabis use disorder (CUD)
Beyond the preview
Go deeper on NCT00893074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00893074.